Information Library
Results for: Clinical Services - Phase II/III - Asia - South Korea
In the complex environment of the New Health, Quintiles is committed to helping you succeed. At every stage of your product’s lifecycle, we are dedicated to delivering real results, being proactive in navigating issues and thinking of new solutions. Search our library today.
- Sort by:
- Recently Added
- Title
-
Energizing Enrollment
Case Study — October 4, 2011
The rapid recruitment for this Phase III, open, randomized, controlled, multi-center study in adjuvant triple-negative breast cancer (TNBC) was completed two months earlier than planned. -
KoNECT & Quintiles Partner to Advance Clinical Research
Press Release — May 30, 2011 – The Korea National Enterprise for Clinical Trials (KoNECT) and Quintiles have partnered to produce educational events in South Korea for investigators and biopharmaceutical companies.
-
QUINTILES PARTNERS WITH THE SEOUL NATIONAL UNIVERSITY HOSPITAL
Press Release — October 6, 2010 – Quintiles celebrates its 10th year anniversary in South Korea by announcing a strategic alliance with the Seoul National University Hospital (SNUH) as part of its unique Prime Site program.
-
Advancing Prevention in Korea
Case Study — September 14, 2010
The original recruitment target and timeline were met with more than 1,100 patients screened to yield 420 randomized patients. -
New FDA Guidance on Antidiabetic Therapies
White Paper — December 11, 2009
Understanding the FDA Guidance on Assessing Cardiovascular Risks for new Antidiabetic Therapies. Learn what FDA cardiac safety requirements may mean for your development program. -
Hepatitis B Vaccine-Successful Study Strategy in Asia
Case Study — November 9, 2009
Quintiles helped a customer overcome recruitment and regulatory challenges for a Hepatitis B vaccine study in Asia.
Page 1 of 1 (6 results)

